The Chicago Entrepreneur

Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial

The stock is on track for its best performance since May 21, 2021, when it gained 127%.

Previous post FTC votes unanimously to block Tempur Sealy’s proposed $4 billion takeover of Mattress Firm
Next post If your mother had Alzheimer’s, your chances of getting it are higher